期刊文献+

穿琥宁的水解动力学研究 被引量:5

Study on Degradation Kinetics of Potassium Dehydroandrographolidi Succinas
下载PDF
导出
摘要 目的 研究穿琥宁溶液的水解动力学特征。方法 使用HPLC法测定穿琥宁水溶液在不同药物浓度,不同pH值的缓冲溶液,不同缓冲对溶液,不同离子强度,不同温度下的水解动力学参数。结果 穿琥宁水解反应符合一级动力学方程。随着pH值增加,穿琥宁降解速率明显增加,在碱性条件下不稳定;随着缓冲溶液浓度的增加,穿琥宁降解速率显著增加;不同的缓冲溶液对穿琥宁降解的催化作用不同;离子强度对穿琥宁降解无显著影响。由阿仑尼乌斯曲线可以看到,温度对穿琥宁的稳定性具有重要影响,穿琥宁在pH8、磷酸缓冲溶液、温度60~90℃下的活化能为95.68KJ/mol。结论 穿琥宁水解属于一级降解反应。降解速率与溶液pH值、缓冲液的浓度、缓冲液的种类及温度有关,溶液pH值对穿琥宁水解影响显著。 Objective To investigate the hydrolytic degradation of the kinetic characteristics of Potassium Dehydroandrographolidi Succinas (DAS-K) in aqueous solution. Methods The HPLC method was used to determine the degradation kinetic parameters of DAS-K aqueous solution at different initial concentration, different pH, different ionic strength, various temperatures and in different buffer solutions. Results DAS-K hydrolytic degradation followed first-order kinetics as measured by HPLC. From pH 8, the hydrolytic degradation rate of DAS-K markedly increased with pH. DAS-K was unstable in alkaline pH solution. The species of buffer solutions seem to have different impact on the catalytic process. The ionic strength did not have significant effect on the stability of the drug. According to the Arrhenius plot, the dependence of the decomposition on temperature was a determining factor, the activation energy was estimated to be 95.68 KJ/mol in phosphate buffer solution at pH 8 and temperature from 60 to 90 ~C. Conclusion It was found that the hydrolytic degradation of DAS-K complied with first-order kinetics. The rate of hydrolytic degradation of DAS-K depended on the pH of solution, the buffer concentration, the buffer species and the temperature. Especially, pH value was an important factor in determining the rate of the hydrolytic degradation of the drug.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2006年第5期794-797,共4页 Journal of Sichuan University(Medical Sciences)
关键词 穿琥宁 水解动力学 高效液相色谱法 Potassium dehydroandrographolidi succinas (DAS-K) Hydrolytic degradation kinetic HPLC
  • 相关文献

参考文献7

  • 1Gilbert SB,Christopher TR.Modern Pharmaceutics.4th Ed.New York:Marcel Dekker,Inc,2002:139-140.
  • 2Michael EA.Pharmaceutics:the science of dosage form design.2nd Ed.London:Harcourt Publishers Limited,2002:130-131.
  • 3Alfonso RG.Remington:the science and practice of pharmacy.2nd Ed.Easton:Mack Publishing Company,1995:643-644.
  • 4Salvatore JT,Robert EK.Sterile Dosage Forms.3rd Ed.Philadelphia:Lea & Febiger,1987:32-33.
  • 5王炳南,贺英菊,龙波,丁志勇,陈林,张运伟,郭玲晓.穿琥宁注射液新处方的拟订及稳定性研究[J].中成药,1999,21(10):493-496. 被引量:8
  • 6Dulal CC,Raymond FG,Joseph FG.Mechanism of hydrolysis of halogenated Nitrosoureas.J Pharm Sci,1978;67(11):1527-1532.
  • 7Alvarez-Lueje A,Sturm J,Squella JA,et al.Hydrolytic degradation of nitrendipine and nisoldipine.J Pharm Biomed Anal,2002;28:393-398.

二级参考文献6

  • 1姚新生.天然药物化学(第二版)[M].北京:人民卫生出版社,1995.459.
  • 2张志勇.-[J].华西医学杂志,1991,6(2):75-75.
  • 3殷恭宽.-[J].药学学报,1998,15(5):288-288.
  • 4安登魁.药物分析[M].-,1994.1106.
  • 5曹春林.中草药制剂注解[M].-,1992.362.
  • 6南就药学院药剂教研组.药剂学(第二版)[M].-,.478.

共引文献7

同被引文献46

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部